Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Queensland Health
Johnson and Johnson
Colorcon
Farmers Insurance
Dow
Argus Health
Medtronic

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020733

« Back to Dashboard

NDA 020733 describes SUBOXONE, which is a drug marketed by Indivior Inc and is included in two NDAs. It is available from four suppliers. There are six patents protecting this drug and three Paragraph IV challenges. Additional details are available on the SUBOXONE profile page.

The generic ingredient in SUBOXONE is buprenorphine hydrochloride; naloxone hydrochloride. There are twenty-nine drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.
Summary for 020733
Tradename:SUBOXONE
Applicant:Indivior Inc
Ingredient:buprenorphine hydrochloride; naloxone hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020733
Suppliers and Packaging for NDA: 020733
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 020733 NDA Physicians Total Care, Inc. 54868-5707 E 54868-5707-0
SUBOXONE buprenorphine hydrochloride; naloxone hydrochloride TABLET;SUBLINGUAL 020733 NDA Physicians Total Care, Inc. 54868-5707 E 54868-5707-1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;SUBLINGUALStrengthEQ 2MG BASE;EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 8, 2002TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;SUBLINGUALStrengthEQ 8MG BASE;EQ 2MG BASE
Approval Date:Oct 8, 2002TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Federal Trade Commission
Cipla
UBS
Colorcon
Cantor Fitzgerald
Baxter
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.